Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

      June 8, 2023

      Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

      June 7, 2023

      Biotechs face challenges as the industry’s annual bash returns to Boston

      June 5, 2023

      The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

      June 5, 2023

      China reaching for biotech breakthroughs in space

      June 2, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Pharmaceutical»Research Finds Common Weed Could Cause Issues for Gluten-Intolerant Population
    Pharmaceutical

    Research Finds Common Weed Could Cause Issues for Gluten-Intolerant Population

    yourbiotechBy yourbiotechMarch 19, 2021Updated:November 11, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The gluten-like proteins determined in ryegrass will be interacting with crops generally used as wheat replacements, which can also cause a reaction amongst human beings with celiac or gluten intolerance.

    Proteins in a not unusual weed determined in gluten-loose crops, which include buckwheat and sorghum, ought to cause problem in human beings affected by gluten intolerance, in accordance to investigate carried out by way of Edith Cowan University (ECU).

    The gluten-like proteins found in ryegrass will be interacting with crops usually used as wheat replacements, which may also reason a reaction among human beings with celiac or gluten intolerance, the take a look at authors referred to.

    The researchers found the proteins in 10 cultivars of ryegrass, which might be an invasive family of weeds generally determined in Australian cereal crops. Sophia Escobar-Correas, a researcher based at ECU, said the crew diagnosed 19 proteins determined in ryegrass that had associated houses to gluten proteins.

    “We have advanced a technique to come across these ryegrass proteins that lets in us to distinguish them from other grains,” Escobar-Correas stated in a press release. “While those proteins aren’t strictly defined as gluten, they have got the ability to trigger reactions for folks who are coeliac and people with a gluten intolerance.”

    This studies helps other investigators recognize whether ryegrass is probably a problem so greater solutions will be developed for the high-quality effects. The subsequent step is to begin medical studies to investigate whether those proteins trigger a celiac response, in keeping with the take a look at authors.

    “If these proteins purpose a reaction for human beings with gluten intolerance, then it’s critical that we broaden tests to locate their presence in meals products which might be otherwise gluten-unfastened,” Escobar-Correas said inside the press launch.

    Michelle Colgrave, ECU professor and co-creator of the research, said they have got diagnosed an crucial capability challenge for gluten-free products.

    “In 2019, the worldwide market for gluten-loose foods was really worth round $6.Three billion and its boom suggests no signal of slowing,” Colgrave stated inside the press launch. “This research will assist give clients and producers self belief that products labelled as gluten-free are unfastened from other proteins which may trigger reactions as a result of agricultural co-mingling.”

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleNCBI events at the Bioinformatics Open Science Conference 2021 (BOSC 2021)
    Next Article Andelyn Biosciences Selects TetraScience as a Strategic Partner for Innovation in Therapeutics Development and Manufacturinga
    yourbiotech
    • Website

    Related Posts

    Pharma company owner duped of ₹1.1 crore

    November 11, 2022

    Novavax cuts full-year revenue forecast again amid weak demand

    November 10, 2022

    Aurobindo units recall products in US market for manufacturing issues

    November 9, 2022

    AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

    November 8, 2022

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.